Megadose The AI curve, compressed.

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

· TechCrunch AI ·
Isomorphic reports “positive preclinical results” in oncology and immunology as it prepares to move drug candidates toward clinical trials.

Greenoaks and Sequoia Capital co-led the $5 billion Series C, with Andreessen Horowitz joining and all existing backers participating. The money will support further development of its AI drug-design engine and expansion into more types of medicine. The round follows a $2.1 billion Series B in May. Isomorphic did not disclose its valuation; Bloomberg previously reported it was seeking $50 billion.

TechCrunch AI's note

score 9

Categories: Money & Moves